GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (STU:SG0) » Definitions » ROE % Adjusted to Book Value

FibroBiologics (STU:SG0) ROE % Adjusted to Book Value : 0.00% (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics ROE % Adjusted to Book Value?

FibroBiologics's ROE % for the quarter that ended in Mar. 2024 was 0.00%. FibroBiologics's PB Ratio for the quarter that ended in Mar. 2024 was N/A. FibroBiologics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was N/A.

FibroBiologics ROE % Adjusted to Book Value Historical Data

The historical data trend for FibroBiologics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics ROE % Adjusted to Book Value Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
- - -

FibroBiologics Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of FibroBiologics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, FibroBiologics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

FibroBiologics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FibroBiologics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where FibroBiologics's ROE % Adjusted to Book Value falls into.


FibroBiologics ROE % Adjusted to Book Value Calculation

FibroBiologics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

FibroBiologics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=0.00% / N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FibroBiologics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of FibroBiologics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

FibroBiologics (STU:SG0) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (STU:SG0) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
Traded in Other Exchanges
FBLG:USA
Address
455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
Website
https://www.fibrobiologics.com
FibroBiologics Inc is an early-stage, cell therapy company. Its primary focus is the initiation and progression of preclinical studies and clinical-stage FDA trials related to fibroblast treatments for Degenerative Disc Disease, Multiple Sclerosis, Cancer, Wound Healing, and other diseases.

FibroBiologics (STU:SG0) Headlines

No Headlines